We are honored and proud that Bristol-Myers Squibb is among Fast Company’s Most Innovative Companies for 2016 and that our passion for developing and delivering transformational medicines helped earn us the number two spot in the rankings’ Biotech category this year.
Sabrina’s cottage on a lake in Quebec is always full of people. While she’s busy living in the city, working at Bristol-Myers Squibb and traveling for her job, she makes sure to spend as many weekends as possible cooking for her large extended family and friends at a getaway she has treasured for years. In quiet moments, you might find her stretched out on a lounge chair on a dock overlooking a seemingly endless lake. She is probably thinking about her work with cancer communities and the patients who are fighting their bouts with cancer.
When her father got sick and struggled to navigate the U.S. healthcare system, Elizabeth realized just how much people are expected to know, and understand, to make the best healthcare decisions for themselves and their families. Elizabeth’s journey to help improve communications with patients by creating a Universal Patient Language puts patients first—and allows patients to co-create materials using plain language and visuals that make sure the information being communicated is simple, understandable and helpful.
Babak immerses himself in his work. As a physician serving patients around the world, he learned more than just how to live and work in remote areas. Living and serving people in neglected communities trained Babak to accommodate the dynamics of isolated, resource-poor populations – cultures of need. His current role leading medical teams, researching new medicines and conducting clinical trials aligns perfectly with his mission to help address areas of significant unmet medical need.
Aparna had only been working as a clinical programmer on Bristol-Myers Squibb’s Global Biometrics Sciences team for six months when five-year-old Tayjus was diagnosed with Duchenne Muscular Dystrophy (DMD). Universal support from managers, co-workers, friends and family has helped her redefine what can be achieved by focusing on one day, and one goal, at a time.
Meet Frederick (also known as Biff), a cancer patient who has gone through a Bristol-Myers Squibb clinical trial. Biff is a proud grandfather of six and talked to his doctor about whether a clinical trial option was an option for him.
Bristol-Myers Squibb is a proud supporter of the Coast 2 Coast 4 Cancer cross country bike ride. Employees of Bristol-Myers Squibb biked nearly 2,900 miles all in support of raising funds for cancer research.
Discovery is in Nils’ DNA. His fascination with chemistry labs began as child, when he tagged along with his father, who was a graduate student at the University of California. As a graduate student at Harvard, Nils learned about a new technology for manipulating the genome of mammals, and was so intrigued that he continued this field of study in a postdoctoral fellowship at Memorial Sloan Kettering Cancer Center in New York. Today, at Bristol-Myers Squibb, Nils leads a drug discovery group responsible for looking for new medicines to help patients overcome serious diseases.